K. Kacena

发表

The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients

G. Rennert, T. Taddei, P. Mistry, 2009, American journal of hematology.

Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1

J. Charrow, C. Hollak, J. Yee, 2009, Genetics in Medicine.

Effect of Enzyme Replacement Therapy With Imiglucerase on BMD in Type 1 Gaucher Disease

P. Kaplan, T. Hangartner, R. Wenstrup, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Life expectancy in Gaucher disease type 1

P. Mistry, P. Velentgas, P. Deegan, 2008, American journal of hematology.

90Y-edotreotide for metastatic carcinoid refractory to octreotide.

E. Van Cutsem, A. Benson, A. Grossman, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gaucher disease and cancer incidence: a study from the Gaucher Registry.

J. Charrow, A. Zimran, B. Rosenbloom, 2005, Blood.

Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoGAA) in treatment-naïve and alglucosidase alfa-treated patients with late-onset Pompe disease: A phase 1, open-label, multicenter, multinational, ascend

B. Byrne, A. Pestronk, P. van Damme, 2019, Neuromuscular Disorders.

Pooling Urine Samples for Ligase Chain Reaction Screening for Genital Chlamydia trachomatis Infection in Asymptomatic Women

M. R. Howell, T. Quinn, C. Gaydos, 1998, Journal of Clinical Microbiology.

Ongoing phase I evaluation of MTD, safety and efficacy of iobenguane I 131 in malignant pheochromocytoma and paraganglioma (Pheo)

R. Coleman, M. Morse, J. Babich, 2008 .

Community infection ratio as an indicator for tuberculosis control

R. Gilman, I. Kohlstadt, L. Cabrera, 1995, The Lancet.

Abstract 18236: Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC): Six Month Safety and Exploratory Efficacy Results

D. Berman, T. Henry, Richard George, 2015 .

Forward-Solution Noninvasive Computational Arrhythmia Mapping: The VMAP Study

Frederick T. Han, Kurt S. Hoffmayer, A. McCulloch, 2022, Circulation. Arrhythmia and electrophysiology.

Eight-Year Clinical Outcomes of Long-Term Enzyme Replacement Therapy for 884 Children With Gaucher Disease Type 1

P. Kaplan, H. Andersson, J. Yee, 2008, Pediatrics.

A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy

Kimberly S. Long, A. Kalra, J. Still, 2021, Advances in Therapy.

The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.

P. Kaplan, H. Andersson, J. Yee, 2006, Archives of pediatrics & adolescent medicine.

Pooling of Urine Samples for Screening for Neisseria gonorrhoeae by Ligase Chain Reaction: Accuracy and Application

Charlotte A. Gaydos, T. Quinn, C. Gaydos, 1998, Journal of Clinical Microbiology.

The risk of Parkinson’s disease in type 1 Gaucher disease

P. Mistry, G. Pastores, M. Boxer, 2010, Journal of Inherited Metabolic Disease.

Glucosylsphingosine is a key biomarker of Gaucher disease

Haiqun Lin, Kate Zhang, W. Chuang, 2016, American journal of hematology.

Use of sentinel pigs to monitor environmental Taenia solium contamination. The Cysticercosis Working Group in Peru (CWG).

R. Gilman, H. García, V. Tsang, 1994, The American journal of tropical medicine and hygiene.

Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex–mediated immune responses

L. Pearce, A. Bitonti, J. Andersen, 2019, Science Advances.

Community infection ratio as indicator for tuberculosis control

R. Hayes, R. Gilman, I. Kohlstadt, 1995, The Lancet.

Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: a multicenter trial.

V. Dilsizian, Ernest V. Garcia, A. Iskandrian, 2010, Journal of the American College of Cardiology.

Machine-learning, MRI bone shape and important clinical outcomes in osteoarthritis: data from the Osteoarthritis Initiative

B. Dube, P. Conaghan, M. Bowes, 2020, Annals of the Rheumatic Diseases.

Effect of Enzyme Replacement Therapy on Bone Mineral Density in Type 1 Gaucher Disease.

P. Kaplan, T. Hangartner, R. Wenstrup, 2005 .

Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial

E. Kerwin, J. Tomassini, L. Baden, 2022, Nature Medicine.

Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial

E. Kerwin, J. Tomassini, I. Frank, 2021, medRxiv.

Abstract CT166: Expansion into multiple institutions for training in the use of the LUM Imaging System for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer

Barbara L. Smith, K. Hunt, A. Chagpar, 2018, Clinical Trials.

B. Byrne, A. Pestronk, P. van Damme, 2019, Neuromuscular Disorders.